AzTrials
AzTrials

Stroke RehabilitationNCT06898073

Dual-task Training During Curved Walking in Stroke Patients

A study testing cognitive dual-task group and Single-task group in people with Stroke Rehabilitation, run by Fooyin University at 1 site in Taiwan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to explore the effects of curved walking training under dual-task conditions on the cognitive function and walking ability of stroke patients. Read more about this study

Who is it for?
Ages 40 to 80 years
Conditions the study is for
Stroke Rehabilitation
What is being tested?
cognitive dual-task group and Single-task group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTaiwan
Study dates
12 Mar 2025to 31 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • First-time unilateral stroke
  • Age between 40 and 80 years
  • Able to walk 10 meters continuously with or without the use of assistive devices
  • Capable of following instructions and performing simple arithmetic
  • Brunnstrom stage 3 or higher

Who cannot join

  • Other neurological disease or unstable medical conditions
  • Visual field defect
  • Mini-Mental State Examination (MMSE) <24 points
  • Pusher syndrome
  • Half-sided neglect
  • Expressive aphasia
  • Poorly controlled hypertension or cardiovascular disease

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Taiwan1 site, 1 recruiting
  • Fooyin University

    Kaohsiung City

    Recruiting

Other trials in Taiwan

About this study

Official title: Effects of Dual-task Training During Curved Walking for Cognitive Function in Stroke Patients

The purpose of this study is to explore the effects of curved walking training under dual-task conditions on the cognitive function and walking ability of stroke patients.

Being tested
cognitive dual-task group, Single-task group

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cognitive dual-task groupBehavioural

    Cognitive tasks as the second task in addition to walking

  • Single-task groupBehavioural

    walking without performing a second task during the walking training

Study groups in NCT06898073
Study groupRoleWhat they receive
Cognitive tasks as the second task in addition to walkingExperimentalNot described
Receives: Behavioral: cognitive dual-task group
walking without performing a second task during the walking trainingOtherNot described
Receives: Behavioral: Single-task group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mini-Mental State Examination

    Mini-Mental State Examination (MMSE) includes items such as orientation, attention, memory, language, verbal comprehension, executive function, and construction ability. The maximum score is 30 points. A higher score indicates better cognitive function. One point is given for each correct answer. A total score below 24 suggests mild cognitive impairment, while a score below 16 indicates severe cognitive impairment.

    Measured: From baseline to the end of treatment at 3 weeks

  2. Trail Making Test

    The test consists of two parts, A and B. In part A, the participant is asked to connect a series of numbers in sequential order as quickly as possible. Part B includes both numbers and colors, where the participant must alternate between connecting the numbers and colors in order. The test records the time taken to complete the sequence and the number of errors made for scoring. If part B is not completed within 5 minutes, the test is stopped, and the highest score of 300 seconds is recorded. A lower score indicates faster completion time, suggesting better function.

    Measured: From baseline to the end of treatment at 3 weeks

  3. Walking ability with different attention loads while turning - time

    The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. The time (seconds) taken to turn will be recorded using a stopwatch.

    Measured: From baseline to the end of treatment at 3 weeks

  4. Walking ability with different attention loads while turning - numbers of steps

    The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. The numbers of steps taken to turn will be recorded using a counter.

    Measured: From baseline to the end of treatment at 3 weeks

  5. Walking ability with different attention loads while turning - gait speed

    The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. Gait speed (m/s) will be recorded using the commercially available portable gait analysis system (Gait Up).

    Measured: From baseline to the end of treatment at 3 weeks

  6. Walking ability with different attention loads while turning - step length

    The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. Step length (cm) during gait will be recorded and analyzed using the commercially available portable gait analysis system (Gait Up).

    Measured: From baseline to the end of treatment at 3 weeks

  7. Walking ability with different attention loads while turning - step time

    The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. Step time (seconds) will be recorded and analyzed using the commercially available portable gait analysis system (Gait Up).

    Measured: From baseline to the end of treatment at 3 weeks

  8. Walking ability with different attention loads while straight-line walking - time

    The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. The time taken to turn will be recorded using a stopwatch.

    Measured: From baseline to the end of treatment at 3 weeks

  9. Walking ability with different attention loads while straight-line walking - numbers of steps

    The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. The numbers of steps taken to turn will be recorded using a counter.

    Measured: From baseline to the end of treatment at 3 weeks

  10. Walking ability with different attention loads while straight-line walking - gait speed

    The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. Gait speed will be recorded using the commercially available portable gait analysis system (Gait Up).

    Measured: From baseline to the end of treatment at 3 weeks

  11. Walking ability with different attention loads while straight-line walking - step length

    The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. Step length (cm) will be recorded using the commercially available portable gait analysis system (Gait Up).

    Measured: From baseline to the end of treatment at 3 weeks

  12. Walking ability with different attention loads while straight-line walking - step time

    The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. Step time (second) will be recorded using the commercially available portable gait analysis system (Gait Up).

    Measured: From baseline to the end of treatment at 3 weeks

  13. Timed up and go test

    This test requires a 3-meter distance to be marked on the floor, with a chair placed at one end. The time which the participant stands up, walks forward to the 3-meter mark, turns around, walks back to the chair, and sits down again will be calculated and recorded.

    Measured: From baseline to the end of treatment at 3 weeks

  14. Time taken to complete the Figure-of-Eight Walk test

    The figure-eight walking test path includes both straight and turning paths. The participant will first be asked to stand between two traffic cones, spaced 5 feet apart. They will then be instructed to walk forward, turn around the first cone in their preferred direction, return to the starting point, and then turn around the second cone in the opposite direction before returning to the center. The time taken to complete the figure-eight walking test will be recorded.

    Measured: From baseline to the end of treatment at 3 weeks

  15. Numbers of steps to complete the Figure-of-Eight Walk test

    The figure-eight walking test path includes both straight and turning paths. The participant will first be asked to stand between two traffic cones, spaced 5 feet apart. They will then be instructed to walk forward, turn around the first cone in their preferred direction, return to the starting point, and then turn around the second cone in the opposite direction before returning to the center. Numbers of steps to complete the Figure-of-Eight Walk test will be recorded.

    Measured: From baseline to the end of treatment at 3 weeks

Secondary outcomes (3)
  1. Berg Balance Scale

    This scale includes 14 test items. The scoring for each item ranges from 0 to 4. Generally, a score of 0 means the participant is completely unable to perform the test, while a score of 4 means the participant can complete the action within the specified time or achieve the maximum required distance or range of motion for the task. Each test item has a clear description of the scoring criteria. The total score is 56, and a higher score indicates better balance ability.

    Measured: From baseline to the end of treatment at 3 weeks

  2. Activities-Specific Balance Confidence scale

    This is a questionnaire that assesses the participant's level of self-confidence in maintaining balance in 16 situations commonly encountered in the community. Each of the 16 items is scored starting from 0, where 0 indicates no confidence, and scores increase in intervals of 10, with a maximum score of 100. A score of 100 represents complete confidence in maintaining balance.

    Measured: From baseline to the end of treatment at 3 weeks

  3. Number of falls

    The number of falls experienced by the participant in the past year will first be recorded. The participant will then be provided with a fall diary to track the number of falls during the one-year follow-up period after the assessment. In this study, a fall is defined as when the individual unintentionally falls to the ground, floor, or another lower level position. Each month, a follow-up phone call will be made to ensure the participant is recording the fall count as required.

    Measured: From baseline to the end of treatment at 3 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Mar 2025
  2. Study start12 Mar 2025
  3. Primary completion31 Jul 2026 (estimated)
  4. Study completion31 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06898073
Sponsor's protocol ID
KSVGH24-CT8-05
Status last verified
Mar 2025
First submitted
9 Mar 2025
Last updated
10 Jun 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing cognitive dual-task group and Single-task group in people with Stroke Rehabilitation, run by Fooyin University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact I-Hsuan Chen (886-7-7811151#7043, Y0894@fy.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mini-Mental State Examination (time frame: From baseline to the end of treatment at 3 weeks). The study lists 15 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2025; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in